Skip to content
Benjamin Joseph Gigliotti, M.D.

Benjamin Joseph Gigliotti, M.D.

Endocrinology, Diabetes & Metabolism

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Locations

Endocrinology

601 Elmwood Avenue, 3rd Floor
Rochester, NY 14620

Endocrinology

2400 South Clinton Avenue, Suite 135
Rochester, NY 14620

About Me

Dr. Gigliotti is a dedicated proponent of Engel and Romano's "Biopsychosocial model" and believes strongly in the value of longitudinal relationships and in caring for the whole patient, not just their disease(s).

Professional Background

Dr. Ben Gigliotti received his undergraduate and medical degrees from the University of Rochester, where he stayed on to train as a resident in Internal Medicine and to serve as chief resident. He completed his Endocrinology fellowship at Massachusetts General Hospital with a strong focus in thyroid...
Dr. Ben Gigliotti received his undergraduate and medical degrees from the University of Rochester, where he stayed on to train as a resident in Internal Medicine and to serve as chief resident. He completed his Endocrinology fellowship at Massachusetts General Hospital with a strong focus in thyroid disorders thanks to mentorship from the MGH Thyroid Unit. In 2018, he returned to the University of Rochester to join the faculty in the Endocrine Division and Department of Medicine.

Dr. Gigliotti is an academic clinical Endocrinologist/Thyroidologist and is the director of URMC's Wolk Thyroid Clinic. He has a passion for caring for patients with thyroid disorders, including thyroid cancers across the risk and age spectrum, thyroid nodules (including performance of fine needle aspiration biopsy), hyperthyroidism, and hypothyroidism, along with parathyroid/metabolic bone disorders and endocrine cancers and hereditary cancer syndromes. He also cares for patients with diabetes, adrenal, pituitary, and reproductive diseases. He is privileged to work in a close multidisciplinary team at the University of Rochester with dear colleagues and friends in endocrinology, endocrine surgery/otolaryngology, nuclear medicine, medical oncology, and radiation oncology.

Dr. Gigliotti's primary academic focus is medical education, and he is deeply committed to training the next generation of medical students, residents, and fellows. He is currently serves as Block Leader for the Endocrinology disease block (in the 2nd year medical student "Disease Processes and Therapeutics" course).

Dr. Gigliotti is an active member of the American Thyroid Association, the Endocrine Society, and the American Association of Clinical Endocrinologists, serving on various national committees. He serves on the editorial board of the journal Thyroid.

Certified Specialties

Endocrinology, Diabetes and Metabolism - American Board of Internal Medicine

Internal Medicine - American Board of Internal Medicine

Faculty Appointments

Assistant Professor - Department of Medicine, Endocrine/Metabolism (SMD)

Credentials

Residency & Fellowship

Fellowship, Internal Medicine, Endocrinology, Diabetes & Metabolism, Harvard Medical School. 2015 - 2018

Residency, Internal Medicine, University of Rochester Medical Center. 2012 - 2014

Internship, Internal Medicine, University of Rochester Medical Center. 2011 - 2012

Education

MD | University of Rochester School of Medicine/Dentistry. 2011

Awards

Arthur W. Bauman Teaching Award. 2020

Primary Care Teaching Award. 2018

Clinical Fellows Excellence in Teaching Award. 2017

Nomination for the Partners Outstanding Resident/Fellow as Teacher Award. 2017 - 2018

Nomination for the Partners Outstanding Resident/Fellow as Teacher Award. 2016 - 2017

Jacob Holler Award. 2015

The Murphy Faculty Award. 2014

William L. Morgan Award. 2013

Class of 1990 Resident Teaching Award. 2013

Arnold P. Gold Foundation's Humanism and Excellence in Teaching Award. 2012

David A. Hallar Award. 2012

Doran J. Stevens Prize. 2011

Dr. Charles Kochakian Award. 2011

Alpha Omega Alpha Medical Honor Society. 2010

Gold Humanism Honour Society. 2010

Disease Processes & Therapeutics Book Award. 2009

Golden Key International Honour Society. 2005

Research

Dr. Gigliotti's research background (fellowship) is in the molecular and microenvironmental profiling of thyroid cancers, along with the development of novel treatments/combination regimens for patients with advanced thyroid cancers, including the use of small molecule inhibitors and immunotherapies...
Dr. Gigliotti's research background (fellowship) is in the molecular and microenvironmental profiling of thyroid cancers, along with the development of novel treatments/combination regimens for patients with advanced thyroid cancers, including the use of small molecule inhibitors and immunotherapies.

Publications

Journal Articles

Effectors enabling adaptation to mitochondrial complex I loss in Hurthle cell carcinoma.

Gopal RK, Vantaku VR, Panda A, Reimer B, Rath S, To TL, Fisch AS, Cetinbas M, Livneh M, Calcaterra MJ, Gigliotti BJ, Pierce KA, Clish CB, Dias-Santagata D, Sadow PM, Wirth LJ, Daniels GH, Sadreyev RI, Calvo SE, Parangi S, Mootha VK

Cancer discovery.. 2023 June 1 Epub 06/01/2023.

International multicentre review of perioperative management and outcome for catecholamine-producing tumours.

Groeben H, Walz MK, Nottebaum BJ, Alesina PF, Greenwald A, Schumann R, Hollmann MW, Schwarte L, Behrends M, Rössel T, Groeben C, Schäfer M, Lowery A, Hirata N, Yamakage M, Miller JA, Cherry TJ, Nelson A, Solorzano CC, Gigliotti B, Wang TS, Wietasch JKG, Friederich P, Sheppard B, Graham PH, Weingarten TN, Sprung J

The British journal of surgery.. 2020 January 107 (2):e170-e178. Epub 1900 01 01.

Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer.

Gunda V, Gigliotti B, Ashry T, Ndishabandi D, McCarthy M, Zhou Z, Amin S, Lee KE, Stork T, Wirth L, Freeman GJ, Alessandrini A, Parangi S

International journal of cancer.. 2019 May 1144 (9):2266-2278. Epub 01/24/2019.

Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer.

Gunda V, Gigliotti B, Ndishabandi D, Ashry T, McCarthy M, Zhou Z, Amin S, Freeman GJ, Alessandrini A, Parangi S

British journal of cancer.. 2018 November 119 (10):1223-1232. Epub 10/17/2018.

Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.

Gopal RK, Kübler K, Calvo SE, Polak P, Livitz D, Rosebrock D, Sadow PM, Campbell B, Donovan SE, Amin S, Gigliotti BJ, Grabarek Z, Hess JM, Stewart C, Braunstein LZ, Arndt PF, Mordecai S, Shih AR, Chaves F, Zhan T, Lubitz CC, Kim J, Iafrate AJ, Wirth L, Parangi S, Leshchiner I, Daniels GH, Mootha VK, Dias-Santagata D, Getz G, McFadden DG

Cancer cell.. 2018 August 1334 (2):242-255.e5. Epub 1900 01 01.

PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma.

Rosenbaum MW, Gigliotti BJ, Pai SI, Parangi S, Wachtel H, Mino-Kenudson M, Gunda V, Faquin WC

Endocrine pathology.. 2018 March 29 (1):59-67. Epub 1900 01 01.

Circulating BRAF Levels Correlate with Treatment in Patients with Thyroid Carcinoma.

Lubitz CC, Zhan T, Gunda V, Amin S, Gigliotti BJ, Fingeret AL, Holm TM, Wachtel H, Sadow PM, Wirth LJ, Sullivan RJ, Panka DJ, Parangi S

Thyroid : official journal of the American Thyroid Association.. 2018 March 28 (3):328-339. Epub 02/27/2018.

In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells.

Frisch BJ, Porter RL, Gigliotti BJ, Olm-Shipman AJ, Weber JM, O'Keefe RJ, Jordan CT, Calvi LM

Blood.. 2009 November 5114 (19):4054-63. Epub 09/02/2009.

Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells.

Weber JM, Forsythe SR, Christianson CA, Frisch BJ, Gigliotti BJ, Jordan CT, Milner LA, Guzman ML, Calvi LM

Bone.. 2006 September 39 (3):485-93. Epub 05/02/2006.

Books

2022 Endocrine Case Management: Meet the Professor (2022)

Chapter: "What's New in the Treatment of Differentiated Thyroid Cancer?"

Authors: Gigliotti BJ

Publisher: The Endocrine Society 2022

A Case-Based Guide to Clinical Endocrinology (2021)

Chapter: "Drug-induced Hypothyroidism."

Authors: Gigliotti BJ

Publisher: Springer-Verlag 2021

Surgery of the Thyroid and Parathyroid Glands (2020)

Chapter: Fine-Needle Aspiration and Molecular Analysis

Authors: Gigliotti BJ, Russell MD, Shonka D, Stathatos N

Publisher: Elsevier, Saunders 2020

Facing Diabetes: A Guide for Patients and their Families (2019)

Chapter: What types of medications and/or other treatments are available to treat diabetes?

Authors: Gigliotti BJ, Wexler D

Publisher: McGraw-Hill Professional, Columbus, OH 2019

Facing Diabetes: A Guide for Patients and their Families (2019)

Chapter: What is insulin, and how is it used to treat diabetes?

Authors: Gigliotti BJ, Wexler D

Publisher: McGraw-Hill Professional, Columbus, OH 2019

Pocket Primary Care (2018)

Chapter: Thyroid Disease

Authors: Gigliotti BJ

Publisher: Lippincott Williams & Wilkins, Philadelphia, PA 2018

Pocket Primary Care (2018)

Chapter: Thyroid Nodules

Authors: Gigliotti BJ

Publisher: Lippincott Williams & Wilkins, Philadelphia, PA 2018

Management of Differentiated Thyroid Cancer (2017)

Chapter: Clinical Presentation and Diagnosis of Hürthle Cell Thyroid Cancer

Authors: Gigliotti BJ, Parangi S

Publisher: Springer International Publishing, Cham, Switzerland 2017

Decision Support in Medicine (2016)

Chapter: Hypogonadism and Testosterone Treatment [Internet]

Authors: Gigliotti BJ, Hayes FJ

Publisher: Clinical Decision Support Programs, Wilmington, DE 2016

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.